Johnson & Johnson (JNJ) Tops Q4 EPS by 4c, Offers FY21 Guidance

Go back to Johnson & Johnson (JNJ) Tops Q4 EPS by 4c, Offers FY21 Guidance

Johnson & Johnson (JNJ) PT Raised to $193 at Credit Suisse

January 27, 2021 7:51 AM EST

Credit Suisse analyst Matt Miksic raised the price target on Johnson & Johnson (NYSE: JNJ) to $193.00 (from $168.00) while maintaining a Outperform rating following the company's 4Q earnings report. JNJs Med Devices results were in line with expectations of a late-Q4 slowdown in elective procedures, consistent... More